Ashley N Moyer
Overview
Explore the profile of Ashley N Moyer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
8
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Morse M, Crosby E, Halperin D, Uronis H, Hsu S, Hurwitz H, et al.
J Neuroendocrinol
. 2025 Feb;
:e13496.
PMID: 39933708
While performing a study of immune checkpoint blockade with the anti-PD-1 antibody pembrolizumab combined with the somatostatin analogue (SSA) lanreotide in patients with low- and intermediate-grade gastroenteropancreatic neuroendocrine tumors (GEP-NETs),...
2.
Kumar A, Owen J, Sloat N, Maynard E, Hill V, Hubbard C, et al.
Curr Oncol
. 2024 Nov;
31(11):7244-7257.
PMID: 39590164
Targeting tumor-specific molecular alterations has shown significant clinical benefit. Molecular tumor boards (MTBs) connect cancer patients with personalized treatments and clinical trials. However, rural cancer centers often have limited access...
3.
Ceppa E, Kim R, Niedzwiecki D, Lowe M, Warren D, House M, et al.
J Am Coll Surg
. 2023 Feb;
236(4):698-708.
PMID: 36728375
Background: Despite institutional perioperative bundles and national infection prevention guidelines, surgical site infection (SSI) after a major abdominal operation remains a significant source of morbidity. Negative pressure therapy (NPT) has...
4.
Strickler J, Rushing C, Uronis H, Morse M, Niedzwiecki D, Blobe G, et al.
Oncologist
. 2021 Jan;
26(6):465-e917.
PMID: 33469991
Lessons Learned: Antitumor activity was observed in the study population. Dose modifications of cabozantinib improve long-term tolerability. Biomarkers are needed to identify patient populations most likely to benefit. Further study...